Skip to main content
logo
Novo Integrated Sciences, Inc. (NVOS)
OTCMKTS · Delayed Price · Currency is USD
0.0031
+0.0001 (3.23%)
Feb 12, 2026, 3:02 PM EST

Novo Integrated Sciences Income Statement

Millions USD. Fiscal year is Sep - Aug.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '24 Aug '23 Aug '22 Aug '21 Aug '20
Revenue
13.2912.5711.749.317.86
Revenue Growth (YoY)
5.75%7.11%26.14%18.38%-16.57%
Cost of Revenue
7.557.626.945.484.8
Gross Profit
5.744.954.83.823.06
Selling, General & Admin
14.0613.5114.398.17.29
Operating Expenses
14.0613.5114.398.17.29
Operating Income
-8.31-8.55-9.59-4.27-4.23
Interest Expense
-7.23-5.12-7.57-0.17-0.16
Interest & Investment Income
0.20.010.170.050.03
Currency Exchange Gain (Loss)
-1.59-0.22-0.64--
Other Non Operating Income (Expenses)
2.560.61-0.02-0.54
EBT Excluding Unusual Items
-14.37-13.27-17.63-4.37-4.89
Impairment of Goodwill
-1--1.36-0.1-
Asset Writedown
-0.76--14.08--0.03
Pretax Income
-16.13-13.27-33.07-4.47-4.92
Income Tax Expense
---0.02--
Earnings From Continuing Operations
-16.13-13.27-33.05-4.47-4.92
Minority Interest in Earnings
-0.040.050.20.010.01
Net Income
-16.17-13.21-32.85-4.46-4.92
Net Income to Common
-16.17-13.21-32.85-4.46-4.92
Shares Outstanding (Basic)
1810322
Shares Outstanding (Diluted)
1810322
Shares Change (YoY)
77.38%248.94%17.59%7.56%5.99%
EPS (Basic)
-0.90-1.30-11.28-1.80-2.13
EPS (Diluted)
-0.90-1.30-11.28-1.80-2.13
Free Cash Flow
-5.07-2.29-6.07-1.28-0.45
Free Cash Flow Per Share
-0.28-0.23-2.08-0.52-0.20
Gross Margin
43.20%39.40%40.89%41.08%38.91%
Operating Margin
-62.54%-68.03%-81.67%-45.93%-53.85%
Profit Margin
-121.61%-105.11%-279.86%-47.95%-62.53%
Free Cash Flow Margin
-38.17%-18.23%-51.75%-13.76%-5.77%
EBITDA
-6.05-6.25-6.57-2.55-2.79
EBITDA Margin
-45.53%-49.72%-55.95%-27.40%-35.47%
D&A For EBITDA
2.262.33.021.721.45
EBIT
-8.31-8.55-9.59-4.27-4.23
EBIT Margin
-62.54%-68.03%-81.67%-45.93%-53.85%
Updated Dec 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.